Skip to content
10-K

Annual Report

Sienna Biopharmaceuticals, Inc.

0001193125-19-074162

← back to feed
Filed
Mar 14, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Mar 8, 2019 30.38M sh
Capex FY 2018 · Dec 31, 2018 $39K
Capex FY 2018 · Dec 31, 2017 $274K
Capex FY 2018 · Dec 31, 2016 $238K
Operating Cash Flow FY 2018 · Dec 31, 2018 −$61.69M
Operating Cash Flow FY 2018 · Dec 31, 2017 −$41.01M
Operating Cash Flow FY 2018 · Dec 31, 2016 −$17.61M
Long Term Debt FY 2018 · Dec 31, 2018 $30.13M
Cash And Equivalents FY 2018 · Dec 31, 2018 $48.53M
Cash And Equivalents FY 2018 · Dec 31, 2017 $74.47M
Stockholders Equity FY 2018 · Dec 31, 2018 $26.58M
Stockholders Equity FY 2018 · Dec 31, 2017 $91.2M
Stockholders Equity FY 2018 · Dec 31, 2016 $22.12M
Stockholders Equity FY 2018 · Dec 31, 2015 $4.05M
Current Liabilities FY 2018 · Dec 31, 2018 $24.35M
Current Liabilities FY 2018 · Dec 31, 2017 $8.24M
Total Liabilities FY 2018 · Dec 31, 2018 $80.73M
Total Liabilities FY 2018 · Dec 31, 2017 $45.65M
Current Assets FY 2018 · Dec 31, 2018 $50.41M
Current Assets FY 2018 · Dec 31, 2017 $77.35M
Total Assets FY 2018 · Dec 31, 2018 $107.31M
Total Assets FY 2018 · Dec 31, 2017 $136.85M
Sga Expense FY 2018 · Dec 31, 2018 $24.91M
Sga Expense FY 2018 · Dec 31, 2017 $18.09M
Sga Expense FY 2018 · Dec 31, 2016 $9.7M
Rd Expense FY 2018 · Dec 31, 2018 $51.59M
Rd Expense FY 2018 · Dec 31, 2017 $30.48M
Rd Expense FY 2018 · Dec 31, 2016 $10.99M
Net Income FY 2018 · Dec 31, 2018 −$19.34M
Net Income FY 2018 · Dec 31, 2018 −$73.47M
Net Income FY 2018 · Sep 30, 2018 −$16.79M
Net Income FY 2018 · Jun 30, 2018 −$20.24M
Net Income FY 2018 · Mar 31, 2018 −$17.1M
Net Income FY 2018 · Dec 31, 2017 −$11.19M
Net Income FY 2018 · Dec 31, 2017 −$50.55M
Net Income FY 2018 · Sep 30, 2017 −$16.39M
Net Income FY 2018 · Jun 30, 2017 −$12.86M
Net Income FY 2018 · Mar 31, 2017 −$10.11M
Net Income FY 2018 · Dec 31, 2016 −$21.16M
Operating Income FY 2018 · Dec 31, 2018 −$76.5M
Operating Income FY 2018 · Dec 31, 2017 −$48.57M
Operating Income FY 2018 · Dec 31, 2016 −$20.69M
Revenue FY 2018 · Dec 31, 2018 $0